Singapore drew S$21.9 billion ($16.2 billion) in investment commitments in 2024, slightly higher than 2023, the Economic ...

Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA ...

Clearside Biomedical, Inc.’s CLSD share price has surged by 10.38%, which has investors questioning if this is right time to ...

MIAMI--(BUSINESS WIRE)--First Ascent Biomedical, a pioneer in personalized cancer treatment, today announced a $6 million investment from Vidal Duart Enterprises, Inc., with an additional co ...

Singapore drew S$21.9bil (US$16.2bil) in investment commitments in 2024, slightly higher than 2023, according to the Economic ...

with an additional co-investment from Techstars. The funding will accelerate First Ascent Biomedical’s mission to transform medical oncology with highly individualized, prospective treatment ...

(Sharecast News) - Ondine Biomedical announced a $4m equity investment from hInsight-NX, a subsidiary of US medical facilities giant HCA Healthcare, on Monday, extending its cash runway through to ...

Singapore drew SG$21.9 billion ($16.2 billion) in investment commitments in 2024, slightly higher than 2023, the Economic Development Board (EDB) said on Thursday as it flagged challenges in 2025 from ...

The investment environment in 2025 is expected to be challenging amid the rise of tariffs and trade wars. Read more at ...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, ...